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High discontinuation rates for depot medroxyprogesterone acetate (DMPA) in 
adolescents may contribute to the number of unintended pregnancies. Many cite vaginal 
bleeding as a reason for discontinuing DMPA use. In this study, we attempted to 
determine if treating DMPA-associated vaginal bleeding with monophasic oral 
contraceptive pills (OCP) raised continuation rates. A total of 131 patients who reported 
vaginal bleeding while on DMPA were included in this study and 83 were treated with 
monophasic OCP. Of those who received OCP, 38.7% reported that vaginal bleeding 
stopped completely, 51.8% reported that vaginal bleeding stopped temporarily, and 6.0% 
reported no change. Overall, 94% of enrolled patients who received OCP as a treatment 
for DMPA-associated vaginal bleeding continued DMPA use. Our findings indicate that 
vaginal bleeding due to DMPA can be successfully treated, leading to improvement in 
continuation rates. 
KEYWORDS: vaginal bleeding, adolescents, depot medroxyprogesterone, DMPA, United 
States 
 
INTRODUCTION 
In a recent prospective study in adult women, continuation rates for depot medroxyprogesterone acetate 
(DMPA) were reported to be 68, 67, and 55% at 6, 9, and 12 months. respectively[1]. In adolescents, 
DMPA continuation rates were even lower. O’Dell et al.[2] found a continuation rate of 34% in 
postpartum adolescents at 12 months. Zibners et al.[3] reported a 45% continuation rate after 1 year in 
adolescent DMPA users attending a midwest urban health clinic[3], and Potter et al.[4] found a 35% 
continuation after 1 year among adolescents attending a rural contraceptive clinic in North Carolina.   
Menstrual changes and prolonged bleeding are common reasons for discontinuation of DMPA[5]. 
Menstrual irregularity was reported by 22% of physicians as the reason patients cited for discontinuation 
of DMPA[6]. Ammerman[7] found that 33% of patients experienced irregular menses or breakthrough 
bleeding on DMPA, which is a rate similar to our finding of 32% in 2002[8]. 
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We performed a retrospective study to evaluate whether treatment with combined oral contraceptive 
pills (OCP) decreased reported bleeding in those on DMPA. A further question was to assess the effect of 
decreased bleeding on continuation rates. As DMPA is highly efficacious (with 0.3 pregnancies per 100 
woman-years vs. 5 pregnancies per 100 woman-years with OCP, and 20 pregnancies per 100 woman-
years with male condoms) and easy to use, increasing rates of continuation in adolescents may decrease 
the number of unintended pregnancies[9]. 
METHODS 
A retrospective review of data was performed utilizing patient charts from a university-based adolescent 
medicine clinic. Patients who were started on DMPA on or after January 1996 were included (n = 538). 
Mean age was 20 years (range 14–20 years) and 56.5% were African-American (see Table 1). Patients 
who reported significant vaginal bleeding (requiring pad/tampon change more than three times a day for 
greater than 1 week) while on DMPA were started on a monophasic OCP containing 250 mcg 
norgestimate and 35 mcg ethinyl estradiol (Ortho-cyclen, Ortho-McNeil Pharmaceuticals, Inc). Patients 
were given one pill by mouth twice a day for 10 days. Those who reported continued significant bleeding 
following 10 days of treatment were treated for 10 additional days. Patients were followed for 18 months 
to assess continuation rates. 
TABLE 1 
Demographic Characteristics 
Age Race Insurance 
Mean age 20 years White 43.5% Medicaid 62.6% 
Standard deviation 1.85 years African-American 56.5% None 13.7% 
Median 20 years   Private 6.9% 
Age range 14–22 years   Unknown 16.8% 
RESULTS 
Vaginal bleeding was reported by a total of 131 (24.3%) women on DMPA in our study; 41% of the 
patients reported bleeding after only one injection, while 29.8% reported continued bleeding after the 
second injection. Of patients reporting significant vaginal bleeding, 83 (63.4%) received OCP. In those 
patients given OCP, 38.6% reported that bleeding was completely halted. Vaginal bleeding was 
temporarily suspended in 51.8%, and 6.0% reported that bleeding did not cease at all. A single course of 
OCP was successful in stopping or significantly reducing vaginal bleeding in 47%, while 26.5% required 
two courses of treatment.   
Continuation rate for DMPA in our clinic overall was 71% at 18 months. Among those with vaginal 
bleeding who received treatment with OCP, we found a 94% continuation rate at 18 months. Of note, the 
6% who were not still on DMPA at 18 months were the same 6% who reported no improvement in 
vaginal bleeding with the OCP treatment. 
DISCUSSION 
Discontinuation of contraceptive method may lead to unintended pregnancies in adolescents. DMPA has 
historically had poor continuation rates[1,2,3,4], which is unfortunate in light of its superior efficacy[9]. 
We found that our clinic sample has a higher-than-average continuation rate at baseline (71%). We 
believe this to be secondary to the comprehensive health care that is provided in our clinic[8]. This 
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number is still unacceptable, as discontinuation leads to lack of protection from pregnancy. As vaginal 
bleeding is a common reason for discontinuation, we may infer that in decreasing this common side 
effect, we were successful in achieving significant improvement in continuation rates for DMPA at 18 
months. 
CONCLUSION 
Decreasing DMPA-associated vaginal bleeding through the use of combination OCP can improve 
continuation rates among adolescents. Improved contraceptive continuation may decrease the rate of 
unintended adolescent pregnancy.  
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